DK266289D0 - Alfa-adrenerge receptorantagonister, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse antagonister - Google Patents

Alfa-adrenerge receptorantagonister, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse antagonister

Info

Publication number
DK266289D0
DK266289D0 DK266289A DK266289A DK266289D0 DK 266289 D0 DK266289 D0 DK 266289D0 DK 266289 A DK266289 A DK 266289A DK 266289 A DK266289 A DK 266289A DK 266289 D0 DK266289 D0 DK 266289D0
Authority
DK
Denmark
Prior art keywords
antagonists
addrenge
alfa
procedures
preparing
Prior art date
Application number
DK266289A
Other languages
English (en)
Other versions
DK266289A (da
Inventor
John Joseph Lafferty
Robert Michael Demarinis
Joseph Walter Venslavsky
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK266289D0 publication Critical patent/DK266289D0/da
Publication of DK266289A publication Critical patent/DK266289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK266289A 1988-06-01 1989-05-31 Substituerede 2-ethenyl-3,4,5,6-tetrahydrofuro(4,3,2-ef)(3)benzazepinforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse DK266289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20088488A 1988-06-01 1988-06-01

Publications (2)

Publication Number Publication Date
DK266289D0 true DK266289D0 (da) 1989-05-31
DK266289A DK266289A (da) 1989-12-02

Family

ID=22743610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK266289A DK266289A (da) 1988-06-01 1989-05-31 Substituerede 2-ethenyl-3,4,5,6-tetrahydrofuro(4,3,2-ef)(3)benzazepinforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse

Country Status (8)

Country Link
EP (1) EP0344980A3 (da)
JP (1) JPH0232081A (da)
AU (2) AU627729B2 (da)
CA (1) CA1320486C (da)
DK (1) DK266289A (da)
PT (1) PT90718B (da)
WO (1) WO1989012050A1 (da)
ZA (1) ZA894097B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229296A (en) * 1988-06-01 1991-05-28 Smithkline Beckman Corp 2-substituted-3,4,5,b-tetrahydrofuran(4,3,2-ef)(3) benzazepine derivatives and pharmaceutical compositions
NZ248852A (en) * 1992-10-28 1997-06-24 Squibb & Sons Inc Alpha-phosphono and phosphinosulphonates and medicaments thereof
US5712396A (en) * 1992-10-28 1998-01-27 Magnin; David R. α-phosphonosulfonate squalene synthetase inhibitors
US5447922A (en) * 1994-08-24 1995-09-05 Bristol-Myers Squibb Company α-phosphonosulfinic squalene synthetase inhibitors
EP2824106B1 (en) * 2012-03-06 2016-11-23 Takeda Pharmaceutical Company Limited Tricyclic compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856910A (en) * 1950-01-10 1974-12-24 Roussel Uclaf Novel thienobenzazepines as anti-depressants
US3649644A (en) * 1969-08-08 1972-03-14 Warner Lambert Co 1 2 3 4 4a 5 6 6a-octahydrobenzofuro (3 2-c)indoles
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
JPS57144286A (en) * 1981-03-02 1982-09-06 Takeda Chem Ind Ltd Azepinoindole derivative and its preparation
US4833244A (en) * 1985-04-22 1989-05-23 Hoechst-Rouseel Pharmaceuticals Inc. Ethanobenzazepines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4769368A (en) * 1986-02-10 1988-09-06 Smithkline Beckman Corporation 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
DE3630539A1 (de) * 1986-09-08 1988-03-10 Madaus & Co Dr Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten
NZ229296A (en) * 1988-06-01 1991-05-28 Smithkline Beckman Corp 2-substituted-3,4,5,b-tetrahydrofuran(4,3,2-ef)(3) benzazepine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
WO1989012050A1 (en) 1989-12-14
AU627729B2 (en) 1992-09-03
PT90718B (pt) 1994-11-30
DK266289A (da) 1989-12-02
EP0344980A2 (en) 1989-12-06
EP0344980A3 (en) 1991-05-15
AU3769089A (en) 1990-01-05
JPH0232081A (ja) 1990-02-01
CA1320486C (en) 1993-07-20
AU3527989A (en) 1990-01-11
ZA894097B (en) 1990-06-27
PT90718A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
DK654589D0 (da) Heterocykliske derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK61189A (da) Stabilt, vaeskeformigt vaskemiddel og toejbloedgoeringsmiddel samt fremgangsmaade til fremstilling heraf
DK219387D0 (da) Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK128688A (da) Thiazolderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK160492C (da) Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater
DK605989A (da) Propenonoximethere og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
DK276189D0 (da) Polypeptidforbindelser, fremgangsmaader til fremstilling heraf farmaceutiske midler indeholdende disse
FI890488A (fi) Vaextextrakt innehaollande farmaceutiska preparat samt foerfarande foer framstaellning daerav.
DK486789D0 (da) Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK642588A (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK66086D0 (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK346889A (da) Heteropolysaccharid bm07, fremgangsmaade til fremstilling deraf samt anvendelse deraf
DK567188D0 (da) 2,2-dimethylchromenderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK13089A (da) Substituerede 5,6,7,8-tetrahydro-4h-thieno-(2,3-d)azepin-forbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK170788A (da) Dihydropyridazinonderivater, fremgangsmaader til fremstilling heraf samt laegemidler indeholdende disse
DK469189A (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK266289D0 (da) Alfa-adrenerge receptorantagonister, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse antagonister
DK674589D0 (da) Benzenderivater og fremgangsmaade til fresmtilling deraf samt farmaceutiske midler indeholdende derivaterne
DK567184D0 (da) Pyridonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK552989D0 (da) Thiazolderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende dem
DK65986A (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK538089D0 (da) Hidtil ukendte tylosinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK115289A (da) Tricykliske aminderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK268889D0 (da) Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
NL193612B (nl) Vergrendelingsinrichting voor container.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment